Filing Details
- Accession Number:
- 0000950170-25-032642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-04 18:42:36
- Reporting Period:
- 2025-02-28
- Filing Date:
- 2025-03-04
- Accepted Time:
- 2025-03-04 18:42:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1294133 | Inogen Inc | INGN | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1638420 | J. Michael Bourque | C/O Inogen, Inc., 859 Ward Drive Goleta CA 93111 | Evp, Cfo & Treasurer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-01 | 600 | $8.33 | 600 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2025-03-01 | 25,000 | $0.00 | 25,600 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-01 | 9,838 | $8.33 | 15,762 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2025-03-01 | 47,625 | $0.00 | 63,387 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-03-01 | 18,741 | $8.33 | 44,646 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2025-03-03 | 3,000 | $8.32 | 47,646 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Acquisiton | 2025-02-28 | 51,020 | $0.00 | 51,020 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2025-03-01 | 25,000 | $0.00 | 25,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 51,020 | No | 4 | A | Direct | ||
| 50,000 | No | 4 | M | Direct |
Footnotes
- Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
- The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2025.
- The reported securities represent shares earned and vested on March 1, 2025 based on achievement of the financial performance conditions for the 2024 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024.
- The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2025.
- Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
- Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.
- 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.
Billionaire Hedge Funds
